InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by MCGUIRE TERRANCE, Director. Insider active across 4 companies, notably Cyclerion Therapeutics, Inc.. Aggregated, 8 filings have been recorded. Total volume traded: €477k. The latest transaction was filed on 16 June 2022 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations8 total
09,459 shares0
Common Stock
SEC:0001209191-22-038544:0·
09,945 shares0
Class A Common Stock
SEC:0001209191-22-038119:0·
0500,000 shares0
Common Stock
SEC:0000899243-21-049595:0·
0500,000 shares0
Common Stock
SEC:0000899243-21-049595·
2,852,425 shares
Common Stock
SEC:0001209191-21-051297·
2,852,425 shares
Common Stock
SEC:0001209191-21-051297:0·
€238,71592,831 shares@ €2.57154.94% mcap100.0% of flow
Common Stock
SEC:0000899243-21-022327·
Ideal exit: 28 Feb 2022 (T+270)
€238,71592,831 shares@ €2.57154.94% mcap50.0% of flow
Common Stock
SEC:0000899243-21-022327:0·
Ideal exit: 28 Feb 2022 (T+270)
8 of 8 declarations
About MCGUIRE TERRANCE
Terrance McGuire is a Board Member at Cyclerion Therapeutics, Inc., Adagio Therapeutics, Inc., and Alector, Inc. He plays a key role in the governance of these companies, participating in strategic decisions and overseeing operations. His experience in the biopharmaceutical sector is valuable for guiding growth initiatives.
